• Jobs
  • Startups
  • Hire
LoginSign up

ElevateBio

Organization banner, image 1 of 6
Organization banner, image 2 of 6
Organization banner, image 3 of 6
Organization banner, image 4 of 6
Organization banner, image 5 of 6
Organization banner, image 6 of 6

ElevateBio has 15 open roles, 6 posted in the last 30 days. Stated pay range: $105k – $330k a year. Funding stage: Series D. Last round: $401M, May 24, 2023.

Open roles

  • ElevateBio logo
    Scientist II, Gene Editing, Protein Engineer

    ElevateBio

    • Waltham, MA
    • Mid-level
    • $125k–$165k
    AI-native
    elevate.bio
    Posted 3d ago
  • ElevateBio logo
    Scientist II, Gene Editing, Protein Engineer

    ElevateBio

    • Waltham, MA
    • Mid-level
    • $125k–$165k
    AI-native
    elevate.bio
    Posted 3d ago
  • ElevateBio logo
    Associate Director, QC Analytics

    ElevateBio

    • Waltham, MA
    • Director / Executive
    • $165k–$225k
    elevate.bio
    Posted 11d ago
  • ElevateBio logo
    Senior Director, Quality Control

    ElevateBio

    • Waltham, MA
    • Director / Executive
    • $240k–$330k
    elevate.bio
    Posted 11d ago
  • ElevateBio logo
    Senior Associate Process Engineer (Contract)

    ElevateBio

    • Waltham, MA
    • Senior
    • $43–$57/hr
    elevate.bio
    Posted 15d ago
  • ElevateBio logo
    Associate Director, Information Security Engineering & Operations

    ElevateBio

    • Waltham, MA
    • Hybrid · Director / Executive
    • $165k–$225k
    AI-native
    elevate.bio
    Posted 23d ago
Show all roles
Unlock human wisdom
ThesisTermsPrivacy

About

ElevateBio logo

ElevateBio

ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) powering the creation of life-transforming therapies. The company helps biopharmaceutical partners design, develop, and manufacture therapies from early discovery through commercialization. Combining proprietary gene editing tools and services, cGMP manufacturing capabilities, and industry-leading expertise, ElevateBio is enabling partners advance a breadth of therapeutic approaches and modalities including cell therapies, gene edited therapies, RNA therapies, mRNA vaccines, and more.

Private companySeries DIn the news
HQWaltham, United States
Size201–500 employees
IndustryPharmaceutical Manufacturing
Funding
  • Series D · $401M · May 24, 2023
Investors
Matrix Capital Management
News
  • ElevateBio Appoints Steven Falcone as Chief Operating Officer
  • ElevateBio Appoints Steven Falcone as Chief Operating Officer

Claim elevate.bio

Work at elevate.bio? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.